SUBSCRIBE
SUBSCRIBE

Revolution Medicines

NEWS
Hand showing money in network. The concept of electronic money.
Drug Development
Revolution Medicines Raises Another $56 Million and Completes Pivot from Antifungal to Cancer Company
Revolution Medicines closed on a Series B financing round worth $56 million. The round was led by Nextech Invest, with participation from Casdin Capital, Schroder Adveq, The Column Group, Third Rock Ventures and undisclosed institutional investors.
April 24, 2018
 · 
2 min read
 · 
Mark Terry
Launched in 2015 with $45 Million, Bay Area Revolution Medicines Scores $25 Million
Biotech Bay
Launched in 2015 with $45 Million, Bay Area Revolution Medicines Scores $25 Million
December 20, 2016
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
April 1, 2025
 · 
4 min read
Press Releases
Revolution Medicines to Participate in April 2025 Investor Conferences
April 1, 2025
 · 
1 min read
Press Releases
Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress
February 26, 2025
 · 
17 min read
Press Releases
Revolution Medicines to Participate in March 2025 Investor Conferences
February 24, 2025
 · 
1 min read
Press Releases
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025
February 19, 2025
 · 
1 min read
Press Releases
Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference
January 30, 2025
 · 
1 min read
Press Releases
Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
 · 
1 min read
Press Releases
Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants
December 4, 2024
 · 
4 min read
Press Releases
Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio
December 3, 2024
 · 
13 min read
Press Releases
Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
November 28, 2024
 · 
1 min read
Load More